Evolving routines: Preventing fatigue associated with lung and colorectal cancer

被引：14

作者：

Olson, K ^{[1
]}

Tom, B ^{[1
]}

Hewitt, J ^{[1
]}

Whittingham, J ^{[1
]}

Buchanan, L ^{[1
]}

Ganton, G ^{[1
]}

机构：

[1] Univ Alberta, Fac Nursing, Edmonton, AB, Canada

来源：

QUALITATIVE HEALTH RESEARCH | 2002年 / 12卷 / 05期

关键词：

D O I：

10.1177/104973202129120160

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Sortie individuals with cancer develop fatigue whereas others do not. To begin the development of a biobehavioral model that could explain this phenomenon, the authors interviewed 29 individuals with lung and colorectal cancer before, during, and after treatment and obtained evaluable data for 18. Blood samples and body weight were obtained at the time of each interview. A three-stage process, evolving routines, and an adaptive behavioral mode labeled gliding characterized those who reported little or no fatigue, even when hemoglobin levels were low. Three other nonadaptive behavioral modes (inertia, disorganization, and overexertion) characterized those who reported fatigue. Individuals with similar disease and treatment profiles seldom demonstrated the same behavioral or biological response patterns.

引用

页码：655 / 670

页数：16

共 30 条

[1]

ABELS R, 1991, BLOOD CELL GROWTH FA, P51

[2]

BARACOS VE, 1994, CLIN J SPORT MED, V4, P223

[3]

Blesch K S, 1991, Oncol Nurs Forum, V18, P81

[4]

Brown L., 1993, Shorter Oxford English Dictionary, VA-M

[5] MUSCLE ELECTROPHYSIOLOGY IN PATIENTS WITH ADVANCED BREAST-CANCER [J].

BRUERA, E ;

BRENNEIS, C ;

MICHAUD, M ;

JACKSON, PI ;

MACDONALD, RN .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (04) :282-285

[6]

Bruera E, 1989, J Pain Symptom Manage, V4, P59, DOI 10.1016/0885-3924(89)90023-7

[7]

CIMPRICH B, 1993, CANCER NURS, V16, P83

[8] SYMPTOM DISTRESS IN NEWLY-DIAGNOSED AMBULATORY CANCER-PATIENTS AND AS A PREDICTOR OF SURVIVAL IN LUNG-CANCER [J].

DEGNER, LF ;

SLOAN, JA .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (06) :423-431

[9] TOXICITY STUDIES OF ADJUVANT INTRAVENOUS VERSUS INTRAPERITONEAL 5-FU IN PATIENTS WITH ADVANCED PRIMARY COLON OR RECTAL-CANCER [J].

GIANOLA, FJ ;

SUGARBAKER, PH ;

BAROFSKY, I ;

WHITE, DE ;

MEYERS, CE .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05) :403-410

[10]

Glaser B., 2006, DISCOV GROUNDED THEO

← 1 2 3 →